Ectropion Inferior–Cleft Lip and/or Palate Syndrome

Blepharo-cheilo-odontic syndrome is a rare condition present at birth. It mainly affects the eyelids (causing the lower eyelids to turn outward—ectropion—so the eyes feel dry, irritated, and watery), the upper lip (causing cleft lip) and/or the roof of the mouth (causing cleft palate), and the teeth (abnormal shape or missing teeth). These problems happen together because of differences in how certain “glue-like” proteins (cadherins and their partners) hold cells together while the face and eyelids form in early development. In many families the condition is autosomal dominant (one changed copy of a gene is enough). Variants in CDH1 (E-cadherin) or CTNND1 (p120-catenin) have been reported. Early diagnosis? helps plan safe feeding, eye protection, speech, and staged surgeries by a cleft/craniofacial team and an oculoplastic surgeon. ScienceDirect+3MedlinePlus+3PubMed+3

Blepharocheilodontic (BCD) syndrome is a birth condition that mainly affects the eyelids, upper lip, and teeth. “Blepharo-” means eyelid, “-cheilo-” means lip, and “-dontic” means teeth. The most visible eye sign is lower-eyelid ectropion, where the lid turns outward and cannot protect the eye surface. People may also have euryblepharon (wide palpebral opening), lagophthalmos (incomplete eye closure), and sometimes an extra row of lashes on the upper lid (distichiasis). The mouth findings include cleft lip with or without cleft palate, plus conical or missing teeth and enamel problems. BCD is rare and usually inherited in an autosomal-dominant way, so a parent with the condition can pass it to a child. There is no single “cure,” but there are many effective supportive treatments and surgeries that protect vision, restore feeding and speech, and improve facial function. MedlinePlus+2NCBI+2

The lower eyelid can become loose or short in front skin, so it folds outward (ectropion). When the lid does not touch the eye, tears do not spread well, and the surface dries out. This causes burning, grittiness, redness, and reflex tearing. In BCD syndrome, ectropion often comes with other eyelid signs (euryblepharon, lagophthalmos) and dental anomalies; cleft lip/palate arises from incomplete joining of facial shelves before birth. Eye symptoms usually improve only after surgical tightening or grafting; drops and ointments are helpful but temporary. FDA Access Data+1

Other names

• Blepharocheilodontic syndrome (BCD syndrome)

• Blepharo-cheilo-dental syndrome (less common wording)

• BCD, type 1 / type 2 (subtypes used in some databases)
  These names all point to the same core triad: eyelid–lip–tooth findings with lower-lid ectropion and clefting. NCBI+1

Types

Doctors sometimes separate BCD by the gene involved:

1. BCD type 1 (CDH1-related) – Changes in CDH1 (the gene for E-cadherin) disturb cell-to-cell adhesion during craniofacial and eyelid development. People typically show the classic triad and eyelid findings (ectropion, euryblepharon, distichiasis). PubMed

2. BCD type 2 (CTNND1-related) – Changes in CTNND1 (p120-catenin) weaken the same adhesion pathway. Features overlap greatly with type 1 (eyelid malformations, cleft lip/palate, tooth anomalies). PubMed+1

Note: Some conditions in the “cleft + eye + tooth” family (for example, EEC syndrome or branchio-oculo-facial syndrome) can look similar but have different genes and patterns. Careful evaluation separates them. PMC+2nfed.org+2

Causes

Main idea: BCD is genetic?. The “causes” below describe what changes the risk or how the biology goes wrong in this syndrome or in close look-alikes. Not every item applies to every patient.

1. Pathogenic variants in CDH1 – The most established cause; disrupts E-cadherin, a key adhesion protein in the face/eyelid/tooth buds. PubMed

2. Pathogenic variants in CTNND1 – Alters p120-catenin, which stabilizes E-cadherin at the cell surface. PubMed

3. Loss-of-function variants – Nonsense/frameshift/critical splice changes remove or truncate essential protein domains, reducing adhesion signals. (Supported generically by gene-function studies in the cited paper.) PubMed

4. Missense variants in functional domains – A single amino-acid change can weaken E-cadherin–p120 binding and disrupt tissue patterning. PubMed

5. Haploinsufficiency – One working copy of CDH1/CTNND1 is not enough to maintain normal development in certain tissues. PubMed

6. Dominant inheritance – BCD is typically autosomal dominant; one altered copy can cause the condition. (Multiple reviews/databases describe dominant transmission.) Genetic Rare Diseases Center+1

7. De novo variants – The change can be new in the child (not present in either parent). Genetic Rare Diseases Center

8. Variable expressivity – The same variant can look different in different people, producing a spectrum of eyelid/cleft/tooth findings. Genetic Rare Diseases Center

9. Reduced penetrance – Some carriers show few or no obvious features, which can complicate family history?. Genetic Rare Diseases Center

10. Pathway disruption in animal models – Experimental loss of Cdh1/Ctnnd1 reproduces eyelid and craniofacial anomalies, proving the mechanism. PubMed

11. Modifier genes – Other genes can modify severity (inferred from variable phenotypes across families). PubMed+1

12. Developmental timing – Early facial fold and palatal shelf formation need intact E-cadherin signaling; disruption at a key time leads to clefting. PubMed

13. Eyelid fusion defects – Temporary eyelid fusion (a normal fetal step) requires E-cadherin; failure can result in euryblepharon/ectropion. PubMed

14. Abnormal migration of neural crest cells – These cells form craniofacial structures; adhesion defects can misguide them. (Mechanistic inference consistent with E-cadherin biology.) PubMed

15. Tooth bud morphogenesis errors – Tooth shape/number depend on cell-cell signaling; pathway failure yields conical teeth or missing teeth. PubMed+1

16. Distichiasis mechanism – Malposition of lash follicles likely relates to abnormal eyelid margin development under adhesion defects. MedlinePlus

17. Environmental modifiers – General teratogens (e.g., maternal smoking or certain meds) can worsen craniofacial outcomes in clefting disorders, though BCD is fundamentally genetic. (General cleft literature; used cautiously as a modifier concept.) PMC

18. Mosaicism in a parent – A parent with few features may carry the variant in some cells, affecting recurrence? risk. (Genetic counseling principle for AD syndromes.) Genetic Rare Diseases Center

19. Epigenetic influences – Gene regulation during palate and eyelid development may modify severity. (Mechanistic context from CDH1 pathway biology.) PubMed

20. Overlap/misclassification with look-alikes – Conditions like EEC or BOFS can look similar; different genes cause them, which is why genetic testing is essential. PMC+1

Symptoms and signs

1. Lower-lid ectropion – The lower eyelid turns outward, exposing the inner surface. Eyes feel dry, irritated, and watery because tears do not spread or drain normally. MedlinePlus+1

2. Euryblepharon – The lower lid may look wide or lax and hang away from the eyeball, compounding exposure symptoms. MedlinePlus+1

3. Lagophthalmos – Trouble closing the eyelids completely during blinking or sleep; worsens dryness and can threaten the cornea?. MedlinePlus

4. Distichiasis – An extra row of upper-lid eyelashes that grow from the inner lining and can rub the eye, causing irritation. MedlinePlus+1

5. Chronic? eye irritation – Redness, burning, gritty sensation from exposure; may need regular lubrication. Cleveland Clinic

6. Photophobia? and tearing – Bright lights hurt; tears may overflow because eyelid position blocks normal drainage. Mayo Clinic

7. Cleft lip (± palate) – A visible split in the upper lip with or without an opening in the roof of the mouth; affects feeding, speech, and facial growth. Orpha

8. Cleft palate alone – Some have only a palate opening; ear infections and speech issues can occur without an obvious lip finding. Orpha

9. Conical or small teeth – Pointed, peg-like teeth that affect bite and appearance; may need dental reconstruction. NCBI

10. Hypodontia – Missing teeth; chewing efficiency and speech can be affected. Genetic Eye Diseases Database

11. Delayed tooth eruption or enamel defects – Teeth come in late or with weak enamel, raising cavity risk. Genetic Eye Diseases Database

12. Recurrent? eye infections – Exposure and lash misdirection can lead to conjunctivitis or keratitis if unprotected. Cleveland Clinic

13. Facial differences – Some have a prominent forehead or hairline changes, adding to a recognizable facial pattern. Genetic Eye Diseases Database

14. Feeding and speech problems in infancy/childhood – Due to cleft palate and dental issues; often improve after repair and therapy. Orpha

15. Rare limb/spine differences – Uncommon reports include limb reduction or spina bifida. Genetic Rare Diseases Center

Diagnostic tests

A) Physical examination 

1. Detailed eyelid and ocular surface exam – An ophthalmologist inspects lid position (ectropion/euryblepharon), lashes (distichiasis), tear film, and cornea for dryness damage. This sets urgency for eye protection. MedlinePlus

2. Blink/closure assessment? (lagophthalmos check) – The clinician watches for incomplete closure and measures the gap. This predicts exposure risk. MedlinePlus

3. Facial/oral exam for clefting – Defines whether the lip, palate, or both are affected; guides timing of surgical repair and feeding plans. Orpha

4. Tooth and bite inspection – A pediatric dentist notes tooth number, shape (conical), enamel quality, and eruption; forms the basis for staged dental care. NCBI+1

5. Tear drainage checks (puncta and eyelid tone) – Simple in-office checks of lid tone and puncta patency help explain tearing and plan management. Mayo Clinic

6. Skin and hair inspection – Looks for lash line abnormalities and any features prompting consideration of look-alike syndromes. MedlinePlus+1

B) Manual/office tests

7. Lid “snap-back” and distraction tests – Gentle manual tests gauge lower-lid laxity; important for deciding on eyelid surgery. (Standard ectropion work-up.) Cleveland Clinic

8. Fluorescein staining of the cornea – Dye highlights dry spots or scratches from exposure or misdirected lashes; guides urgency of lubrication or protective surgery. Mayo Clinic

9. Schirmer test (tear production) – Paper strip test measures baseline? tears in exposure-dry eye. Cleveland Clinic

10. Refraction and visual acuity? – Finds glasses needs and screens for amblyopia risk if the cornea is affected. Cleveland Clinic

11. Speech-language screening? – Early screen for resonance and articulation problems in cleft palate; directs therapy. Orpha

C) Laboratory / pathological / genetic 

12. Targeted gene testing for CDH1 and CTNND1 – Confirms diagnosis and informs recurrence risk; the hallmark lab test in suspected BCD. PubMed

13. Sequencing with deletion/duplication analysis – Detects small and large changes that standard sequencing might miss. PubMed

14. Trio testing (child + parents) – Distinguishes inherited vs. de novo variants and can uncover parental mosaicism. Genetic Rare Diseases Center

15. Exome/genome sequencing if initial panel is negative – Useful when features are suggestive but targeted tests are unrevealing. (General genetics approach; applied when BCD is suspected.) Genetic Rare Diseases Center

16. Dental material analysis (as needed) – If teeth are extracted, pathology can document enamel/dentin defects to guide restorations. (Adjunctive dental practice.) Genetic Eye Diseases Database

D) Electrodiagnostic 

17. Facial nerve conduction / blink reflex EMG? – Consider only if ectropion severity seems out of proportion and a facial nerve problem is suspected (e.g., acquired palsy). Typically normal in congenital? BCD. (Electrodiagnostics are for exclusion, not routine.) Cleveland Clinic

18. Electroretinography or visual evoked potentials – Reserved for unusual cases with suspected retinal/optic pathway issues; not standard for BCD, but can rule out other ocular disorders if vision is atypical?. (General ophthalmic practice.) Cleveland Clinic

E) Imaging 

19. Dental panoramic radiograph? (OPG) – Maps missing/impacted teeth, root shape, and helps plan orthodontics/implants. Genetic Eye Diseases Database

20. Cephalometric radiographs / craniofacial CT? (as needed) – Define cleft pattern, maxillary growth, and surgical planning. MRI? is added only for rare associated spinal findings. Orpha+1

Non-pharmacological treatments (therapies & other supports)

1. Eye lubrication routine (daytime artificial tears + nighttime ointment).
   What it does: Keeps the eye surface wet, reduces burning, redness, and risk of scratches.
   Purpose: Replace the missing protection from a turned-out lid.
   How it works: Tears and gel/ointment form a protective film that lowers friction and evaporation so the cornea stays smooth and clear. Regular, frequent use is more important than brand; put drops by day and thicker ointment before sleep to prevent overnight exposure. (Combine with lid taping at night if needed; see below.) Evidence and expert guidance emphasize ocular-surface protection as first-line care in congenital ectropion and lagophthalmos. Genetic Eye Diseases Database+1

2. Nighttime eyelid taping or moisture-chamber goggles.
   Purpose: Keep the eye closed during sleep to stop drying.
   Mechanism: Gentle medical tape or a soft moisture shield reduces air flow and exposure; this preserves the tear film and prevents morning corneal damage in people who cannot fully close the eye. Use skin-safe tape and check with ophthalmology for technique. Genetic Eye Diseases Database

3. Warm compresses and lid hygiene.
   Purpose: Soothe the exposed lid margin and support any remaining oil glands.
   Mechanism: Warmth loosens thick oils; gentle cleansing removes crusts and bacteria, helping comfort and tear-film stability. (In some related syndromes meibomian glands may be reduced or absent; hygiene still helps the lid margin stay clean.) PMC+1

4. Punctal occlusion (temporary plugs).
   Purpose: Keep tears on the eye longer when dryness persists.
   Mechanism: Soft silicone plugs placed by an eye doctor reduce tear drainage so natural and artificial tears last longer on the surface. This can be a bridge while planning surgery. EyeWiki

5. Scleral contact lenses (specialist-fitted).
   Purpose: Create a liquid “bath” over the cornea for comfort and clear vision.
   Mechanism: A large rigid lens vaults over the cornea and holds sterile saline against the eye all day, shielding it from air and friction—useful when lids cannot protect the eye well. EyeWiki

6. Sun- and wind-protection (wraparound glasses; humidifier).
   Purpose: Reduce evaporation and irritation outdoors and in dry rooms.
   Mechanism: Physical barriers keep air from stripping the tear film; room humidifiers raise moisture to protect the cornea.

7. Speech-language therapy (post-cleft repair).
   Purpose: Improve speech clarity and feeding skills in children with cleft palate history.
   Mechanism: Regular exercises target velopharyngeal function and articulation patterns that can be affected by early palate differences. Orpha

8. Feeding support in infancy (cleft-adapted bottles, positioning).
   Purpose: Achieve safe nutrition before and after palate repair.
   Mechanism: Special nipples/bottles and upright positioning compensate for impaired suction across a palatal gap, reducing aspiration and improving weight gain. Orpha

9. Early dental/orthodontic care (sealants, space maintenance).
   Purpose: Protect fragile enamel, guide bite and spacing, and plan for missing or conical teeth.
   Mechanism: Preventive sealants and fluoride strengthen enamel; interceptive orthodontics manages spacing until prosthetic solutions are ready. Orpha

10. Psychosocial support and family counseling.
    Purpose: Support confidence, schooling, and family coping around visible differences and surgeries.
    Mechanism: Counseling, peer groups, and school coordination reduce anxiety and improve adherence? to care plans.

11. Scar care and sun protection after cleft surgery.
    Purpose: Optimize scar appearance and comfort.
    Mechanism: Silicone gel/sheets and SPF minimize hypertrophic change and discoloration.

12. Multidisciplinary cleft/craniofacial team follow-up.
    Purpose: Coordinate eye, cleft, dental, hearing, and genetic needs through growth.
    Mechanism: Scheduled visits align procedures and therapies for best long-term function. Orpha

13. Genetic counseling.
    Purpose: Explain inheritance, recurrence risk, and options for family planning.
    Mechanism: Pedigree review and education for autosomal-dominant disorders. Orpha

14. Hearing checks and ENT support.
    Purpose: Detect middle-ear problems common with cleft palate.
    Mechanism: Tympanometry and audiology guide early tube placement if needed. Orpha

15. Eye-safe hygiene and infection? avoidance.
    Purpose: Reduce conjunctival infections on an exposed surface.
    Mechanism: Hand hygiene, clean towels, and early assessment for redness/discharge.

16. Physiotherapy for facial closure practice (as advised by specialists).
    Purpose: Help comfortable eyelid closure when possible.
    Mechanism: Gentle, guided exercises under clinician advice.

17. Nutritional guidance for enamel and wound healing.
    Purpose: Support healthy teeth and surgical recovery.
    Mechanism: Adequate protein, vitamins A/C/D/K2, calcium, and hydration.

18. School care plan for eye drops and sun safety.
    Purpose: Keep routines during the day.
    Mechanism: Written plan with teachers and the school nurse.

19. Regular photography and vision checks.
    Purpose: Track exposure spots, corneal clarity, and lid position over time.
    Mechanism: Baseline photos and periodic exams catch changes early.

20. Emergency? plan for corneal injuries.
    Purpose: Treat scratches/ulcers quickly.
    Mechanism: Know which clinic to call and the warning signs (pain?, light sensitivity?, sudden blur).

Drug treatments

Important: No medicine “cures” the genetic syndrome. These medicines treat symptoms and complications (dry eye from exposure, surface inflammation?, infection prevention/treatment, peri-surgical care). Always use under a clinician’s guidance, especially in infants/children.

1. Cyclosporine ophthalmic emulsion 0.05% (brand: RESTASIS; multiple generics).
   Class: Topical immunomodulator (calcineurin inhibitor). Dose/Time: 1 drop in each eye twice daily, ~12 hours apart. Purpose: Boost basal tear production in inflammatory dry eye that often accompanies exposure. Mechanism: Lowers T-cell–mediated inflammation in lacrimal functional unit, allowing tear production to recover. Side effects: Burning on instillation; less commonly redness, discharge, tearing, stinging, blur. Evidence is from FDA labeling for dry eye; use is off-label to support exposed corneas in ectropion. FDA Access Data

2. Lifitegrast ophthalmic solution 5% (brand: Xiidra; generics).
   Class: LFA-1/ICAM-1 antagonist (anti-inflammatory? for dry eye). Dose/Time: 1 drop twice daily, ~12 hours apart. Purpose: Reduce signs/symptoms of inflammatory dry eye that worsen exposure keratopathy. Mechanism: Blocks T-cell adhesion/activation in ocular surface inflammation. Side effects: Transient irritation, taste disturbance (dysgeusia). FDA Access Data+1

3. Moxifloxacin 0.5% ophthalmic (brands: VIGAMOX/Moxeza).
   Class: Fluoroquinolone antibiotic? eye drop. Dose/Time: Per label (e.g., 1 drop 3×/day for 7 days in bacterial conjunctivitis). Purpose: Treat bacterial conjunctivitis or corneal abrasion-associated infection risk in an exposed eye. Mechanism: Inhibits DNA gyrase/topoisomerase IV. Side effects: Local irritation; avoid unnecessary use to limit resistance. FDA Access Data+1

4. Fluorometholone 0.1% ophthalmic (FML/Flarex).
   Class: Topical corticosteroid. Dose/Time: Short courses as prescribed for sterile inflammation; then taper. Purpose: Calm surface inflammation from chronic exposure (specialist-directed). Mechanism: Down-regulates inflammatory cytokines. Side effects: Increased intraocular pressure, cataract risk, infection masking—use with monitoring. FDA Access Data+1

5. Erythromycin ophthalmic ointment (clinical common practice; use an FDA-listed ophthalmic brand/label in your region).
   Class: Macrolide antibiotic ointment. Dose/Time: Thin ribbon in the lower fornix 2–4×/day when infection risk is high (e.g., exposure, abrasions). Purpose: Lubricating antibiotic barrier at night. Mechanism: Inhibits bacterial protein synthesis. Side effects: Temporary blur, irritation. (Note: Use an ophthalmic-specific label; topical skin products are not for eyes.) FDA Access Data

6. Acetaminophen (paracetamol) oral/IV (age-appropriate formulations).
   Class: Analgesic/antipyretic. Dose/Time: Weight-based; do not exceed total daily maximum per label. Purpose: Control pain after cleft surgery or dental work. Mechanism: Central COX modulation. Side effects: Hepatotoxicity if overdosed; check all combination products. FDA Access Data+1

7. Ibuprofen oral suspension (pediatric, over-the-counter strength).
   Class: NSAID. Dose/Time: Weight-based every 6–8 hours with food, not for very young infants unless directed. Purpose: Pain and inflammation relief after procedures. Mechanism: COX-1/COX-2 inhibition. Side effects: GI upset, rare kidney effects; avoid in dehydration. FDA Access Data+1

8. Amoxicillin oral suspension or tablets (peri-operative/ENT/dental indications as prescribed).
   Class: Aminopenicillin antibiotic. Dose/Time: Weight-based course per indication. Purpose: Treat ENT, dental, or postoperative infections when indicated. Mechanism: Inhibits bacterial cell wall synthesis. Side effects: Rash, diarrhea; avoid with severe β-lactam allergy. FDA Access Data

9. Fluticasone propionate nasal spray (representative intranasal corticosteroid label).
   Class: Intranasal steroid. Dose/Time: Once or twice daily per label. Purpose: Reduce nasal mucosal swelling that can worsen mouth-breathing and dryness after cleft repairs/ENT issues. Mechanism: Local anti-inflammatory effect. Side effects: Local irritation, epistaxis.

10. Chlorhexidine gluconate 0.12% oral rinse (Peridex/Periogard).
    Class: Antimicrobial mouthwash. Dose/Time: Rinse as directed for gingivitis control in high-risk dentition (conical/missing teeth). Purpose: Reduce plaque/gingivitis during orthodontic or prosthetic phases. Mechanism: Disrupts bacterial cell membranes. Side effects: Tooth staining, taste changes; do not swallow. FDA Access Data+1

11. Topical fluoride varnish (5% NaF; device/510(k) cleared).
    Class: Topical dental fluoride. Use: Applied in the dental clinic at intervals. Purpose: Remineralize enamel, reduce sensitivity, and protect high-risk teeth. Mechanism: Fluoride enhances enamel resistance to acid. Notes: Regulated as a device; labeling varies by product. FDA Access Data+1

12. Short-course topical antibiotic/steroid combinations (specialist-directed when clearly indicated).
    Purpose/Mechanism: Reduce mixed inflammation and bacterial load in acute flares; Risks: pressure rise, fungal/viral masking—use only under ophthalmology.

(Items typically repeat the above classes in age-appropriate brands and formulations; in this condition, drug therapy is supportive, not disease-modifying. Your clinicians will select from these labeled medicines based on age, severity, and surgery timing.)

Dietary molecular supplements

Supplements never replace medical/surgical care, but can support wound healing, enamel strength, and ocular surface health when diet is insufficient.

1. Vitamin A (retinol/beta-carotene).
   Dose: As advised; avoid excess. Function: Supports corneal epithelium and immune defense. Mechanism: Regulates epithelial differentiation and mucin gene expression that protect the ocular surface.

2. Vitamin D3.
   Dose: Per blood levels and age guidelines. Function: Bone/teeth mineralization and immune modulation. Mechanism: Enhances calcium absorption; affects innate immunity.

3. Vitamin C.
   Dose: Daily RDA or peri-operative higher (as advised). Function: Collagen synthesis for wound healing and scar quality. Mechanism: Cofactor for prolyl/lysyl hydroxylases.

4. Vitamin K2 (MK-7).
   Dose: Typical daily supplemental range under clinician advice. Function: Directs calcium to bones/teeth. Mechanism: γ-carboxylation of osteocalcin and MGP.

5. Calcium.
   Dose: Age-appropriate daily intake. Function: Tooth/bone strength. Mechanism: Mineral substrate for hydroxyapatite.

6. Magnesium.
   Dose: RDA-based. Function: Enamel/bone metabolism cofactor. Mechanism: Enzyme activation and mineral homeostasis.

7. Omega-3 fatty acids (EPA/DHA).
   Dose: Typical 500–1000 mg/day combined EPA/DHA in older children/adults (ask pediatrician for child dosing). Function: Support tear-film lipid layer and calm surface inflammation. Mechanism: Pro-resolving lipid mediators in ocular surface.

8. Zinc.
   Dose: RDA-based. Function: Epithelial repair and immune support. Mechanism: Enzymatic cofactor in DNA synthesis/wound repair.

9. Probiotics (e.g., Lactobacillus/Bifidobacterium).
   Dose: Per product. Function: Gut support during/after antibiotics and peri-operative periods. Mechanism: Microbiome modulation.

10. Collagen/gelatin with vitamin C (peri-operative).
    Dose: As advised short-term around surgery. Function: Scar and tissue repair support. Mechanism: Provides amino acids for collagen formation, with vitamin C as cofactor.

Immunity-booster / regenerative / stem-cell–related” therapies

1. Autologous serum eye drops (specialist compounded).
   Dose: Several times daily per protocol. Function: Supplies growth factors and vitamins similar to natural tears. Mechanism: Patient’s serum acts as a biologic tear substitute to heal persistent epithelial defects.

2. Platelet-rich plasma (PRP) eye drops (compounded).
   Function: Adds concentrated growth factors. Mechanism: Platelet-derived factors stimulate epithelial repair on the cornea.

3. Amniotic membrane grafts (suture or self-retaining).
   Function: Biological bandage for non-healing corneal defects. Mechanism: Anti-inflammatory, pro-healing basement membrane.

4. Limbal stem-cell–supportive care (when deficiency suspected).
   Function: Protect and stabilize limbal niche. Mechanism: Aggressive lubrication, bandage lenses, and staged surgery prevent stem-cell loss.

5. Nutritional immune support (vitamin D, zinc, omega-3s as above).
   Function/Mechanism: Modulate innate/adaptive immunity and inflammation.

6. Future gene-directed counseling (family planning).
   Function: Reduces recurrence risk via informed choices. Mechanism: Uses confirmed autosomal-dominant inheritance knowledge. Orpha

Surgeries (what they are & why done)

1. Lower-lid ectropion repair (canthoplasty/canthopexy, skin-muscle tightening, or grafts).
   Why: Turn the lid back inward so it touches the eye, protecting the cornea and improving tear distribution. Procedure: Tailored to anatomy; may tighten the outer lid corner and add/redistribute skin or support tissues. AJO

2. Temporary tarsorrhaphy (partial eyelid closure).
   Why: Emergency or interim protection for a dangerously exposed cornea. Procedure: Sutures bring lids partially together to reduce exposure while healing occurs.

3. Cleft lip repair (cheiloplasty).
   Why: Restore lip seal for feeding, speech, and appearance. Procedure: Performed in infancy; reconstructs muscle continuity and symmetry.

4. Cleft palate repair (palatoplasty).
   Why: Separate mouth and nose cavities for normal speech and feeding. Procedure: Usually in the first year or so; sometimes staged; may need later speech surgery. Orpha

5. Alveolar bone grafting and later orthognathic/dental prosthetic surgery.
   Why: Stabilize the dental arch, allow tooth eruption/implants, and correct jaw alignment for function and appearance. Procedure: Grafts placed in the gum ridge; later orthodontic and prosthetic steps complete the bite. Orpha

Preventions

1. Keep to a daily lubrication plan (drops by day, ointment by night).

2. Use wraparound sunglasses/wind shields outdoors.

3. Run a humidifier in dry rooms, especially during sleep.

4. Do not rub eyes; use clean tissues and hand hygiene.

5. School/day-care plan for drops, sun safety, and eye protection.

6. Prompt care for red, painful, or light-sensitive eyes.

7. Dental checkups every 3–6 months with fluoride/pro sealants.

8. Nutrient-dense diet for enamel and wound healing.

9. Speech therapy follow-through after cleft repair.

10. Family genetic counseling before future pregnancies. Orpha+1

When to see doctors (red flags)

• Eye pain, light sensitivity, sudden blur, or white spot on the cornea (possible abrasion/ulcer).

• Persistent redness or discharge unresponsive to lubrication.

• Inability to close the eye or worsening outward lid droop.

• Feeding trouble, poor weight gain, nasal regurgitation in infants with cleft palate.

• Speech concerns or nasal voice after repair.

• Tooth pain, enamel chips, bleeding gums, or lost space/retainers.

• Hearing problems (ear fluid/infections).
  These signs need same-day or timely specialist assessment. Orpha

What to eat” and “what to avoid

Eat more:

1. Soft, protein-rich foods after surgery (eggs, yogurt, dal, fish).

2. Vitamin-C fruits/veg (guava, oranges, bell pepper) for wound healing.

3. Dairy/fortified alternatives for calcium + vitamin D (milk, curd, soy).

4. Leafy greens for K, magnesium, and minerals.

5. Omega-3 sources (fish, flax, walnuts) for surface inflammation.

Avoid/limit:

1. Hard, sticky candies that crack enamel or pull appliances.
2. Sugary snacks/drinks between meals (cavity risk).
3. Very hot/spicy foods right after oral surgery.
4. Dehydration—drink water regularly for tear and mucus layers.
5. Excess supplements—more is not better; follow doses.

FAQs

1) Is BCD syndrome the same as “ectropion + cleft lip/palate” syndrome?
It’s the most consistent match: BCD combines lower-lid ectropion with cleft lip ± palate and dental changes. Clinicians confirm by exam and genetics. Orpha

2) What causes it?
Most cases are genetic and inherited in an autosomal-dominant pattern—one affected parent can pass it on. Gene panels help confirm. Orpha

3) Can eye drops cure the lid problem?
Drops protect the surface but don’t move the lid. Surgery is often needed to restore lid-to-eye contact for lasting protection. AJO

4) Will vision be normal?
With early protection of the cornea, regular exams, and timely surgery, many people keep good vision. Delays increase risk of scars or infection.

5) What age is best for cleft repairs?
Lip repair is usually in early infancy; palate within the first year or so, with team-specific timing. Your cleft team will individualize. Orpha

6) Why do eyes feel dry even with tears?
Exposure and poor eyelid closure let tears evaporate fast; inflammation also lowers natural tear quality. Anti-inflammatory drops can help. FDA Access Data+1

7) Are scleral lenses safe for kids?
In specialist hands and with hygiene, they can be very helpful for severe exposure; fitting and follow-up are key. EyeWiki

8) What dental issues should we expect?
Conical, missing, or weak enamel teeth are common; early dental prevention, fluoride, and orthodontics reduce long-term problems. Orpha

9) Will my child need multiple surgeries?
Often yes: cleft lip/palate repairs, possible lid surgery, later dental/alveolar grafting or jaw procedures, and speech steps over time. Orpha

10) Can we prevent eye infections?
Yes—lubrication, hygiene, and seeking care early for redness or pain. Antibiotics are for proven infections, not routine long-term use. FDA Access Data

11) Are there special school precautions?
Have a plan for eye drops, sun/wind protection, and safe play; teachers should know when to call parents for eye symptoms.

12) Does screen time worsen dryness?
Long staring reduces blinking. Take “20-20-20” breaks and use drops as advised.

13) Could there be hearing problems?
Cleft palate raises risk of middle-ear fluid and infections; regular audiology checks help. Orpha

14) Is genetic counseling useful if no one else in the family is affected?
Yes. New (de novo) variants can occur; counseling explains recurrence risks and testing options. Orpha

15) What’s the long-term outlook?
With coordinated team care, most people do well—seeing, speaking, eating, and smiling more comfortably. Lifelong check-ups keep problems small.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: October 27, 2025.